A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)
CompletedOBSERVATIONAL
Enrollment
154
Participants
Timeline
Start Date
October 31, 2007
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Conditions
Ovarian NeoplasmsBreast NeoplasmsParesthesia
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00746694 - A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020) | Biotech Hunter | Biotech Hunter